Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.
about
The osteocyte as a therapeutic target in the treatment of osteoporosisLRP5 and LRP6 in development and diseaseControl of bone formation by the serpentine receptor Frizzled-9Dkk1 stabilizes Wnt co-receptor LRP6: implication for Wnt ligand-induced LRP6 down-regulation.Identification of novel genes associated with fracture healing in osteoporosis induced by Krm2 overexpression or Lrp5 deficiency.Osteoblast-specific Krm2 overexpression and Lrp5 deficiency have different effects on fracture healing in mice.The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitorsHigh-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes.Ablation of the pro-apoptotic protein Bax protects mice from glucocorticoid-induced bone growth impairmentUpdate on Wnt signaling in bone cell biology and bone disease.Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5.Wnt signaling in bone development and disease: making stronger bone with WntsThe role of midkine in skeletal remodelling.Wnt and the Wnt signaling pathway in bone development and disease.Effects of pulsed electromagnetic fields on postmenopausal osteoporosis.Structure of the Dual-Mode Wnt Regulator Kremen1 and Insight into Ternary Complex Formation with LRP6 and Dickkopf.The Anti-Osteoanabolic Function of Sclerostin Is Blunted in Mice Carrying a High Bone Mass Mutation of Lrp5.Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin.Predominant role of PDGF receptor transactivation in Wnt3a-induced osteoblastic cell proliferation.Bioinformatics analysis of gene expression profile in callus tissues of osteoporotic phenotype mice induced by osteoblast-specific Krm2 overexpression.
P2860
Q27009129-93BA828B-B966-4590-8D3D-5F72BE8F9EDBQ27692072-F43A4EC9-06E7-4150-93F3-5B7F4C992B7EQ28587080-DD924F58-FDF0-4B4B-8E6D-B076151C5EF8Q33603037-5E740CA6-3642-4847-A920-F0EFEA8B1AAFQ33702201-D25B4717-2B49-4223-9FDC-D43F77210EE8Q33952489-EF2E4EDC-02A6-474A-8ED4-0E6865D8CF68Q34428195-8D46EE84-6A23-4009-BBEC-49CE6D4DA07AQ35755147-F16498C1-DF8B-49B3-973F-AAEEE058E9E6Q35839866-0A5791AA-6B04-4A02-B01A-7438DD4494ADQ36083303-695F5B30-21BA-4673-BCF0-65FC52C86AFCQ36318608-0A3EC2C7-A10E-4C97-A167-437B55F4FFB5Q36418026-1D059CF3-D589-4EAF-9A40-B1943F52439CQ37585395-80372AA9-4213-40C9-BA14-DBF96D77B139Q37724188-BC145DAC-8F70-4CD0-8D00-05DA35622393Q38664528-F686DEE5-7ED8-41CB-AB56-7775380BED8BQ41033242-2BE24655-6BFF-480C-BD29-C5E52F501F59Q41498366-C7F2D747-E917-4AC0-9839-3714DA6B1903Q42174982-8C55FEFC-1624-4F1C-B6D1-28960D85F7FBQ47215693-689E724B-1F1F-4D0C-8512-41B596F52903Q47881918-951EA234-9BD5-4258-8ADA-6D4AB93BB2F3
P2860
Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.
@ast
Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.
@en
Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.
@nl
type
label
Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.
@ast
Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.
@en
Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.
@nl
prefLabel
Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.
@ast
Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.
@en
Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.
@nl
P2093
P2860
P1433
P1476
Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2
@en
P2093
Alexander S Spiro
Anke Baranowsky
Arndt F Schilling
Christof Niehrs
Felix W Friedrich
Hiroaki Saito
Joachim Albers
Jochen Schulze
Jozef Zustin
Kristina Ellwanger
P2860
P304
P356
10.1371/JOURNAL.PONE.0010309
P407
P50
P577
2010-04-27T00:00:00Z